Pharmaceutical and Diagnostic Company (NDA)
Our client is a global innovative pharmaceutical and diagnostic company that uses cutting-edge science to improve people's lives.
Combining the pharmaceutical and diagnostic divisions allows them to be one of the leaders in the field of personalized medicine — a strategy aimed at developing effective medical solutions for patients, taking into account the individual characteristics of each.
-
127 million
Patients are treated with their drugs in a year
-
26
Their drugs are included in the list of VED in Russia
Our client is one of the largest producers of biotechnological medicines for the treatment of oncological, autoimmune, infectious, and ophthalmological diseases and disorders of the central nervous system.
The company is also one of the leaders in the field of in-vitro diagnostics and histological diagnostics of oncological diseases, as well as a pioneer in the field of self-control of diabetes mellitus.
Companies started working together on a joint project to implement Russian localization as part of the Russian Add-On package in 2018.